NCI, Inc. (NASDAQ:NCIT) was upgraded by equities research analysts at ValuEngine from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday, June 2nd.

A number of other brokerages also recently commented on NCIT. Cowen and Company reissued a “buy” rating and issued a $16.50 price target on shares of NCI in a report on Monday, April 10th. Noble Financial restated a “buy” rating on shares of NCI in a research note on Friday, May 12th. Zacks Investment Research upgraded NCI from a “sell” rating to a “hold” rating in a research note on Saturday, May 13th. Finally, FBR & Co reiterated a “hold” rating and set a $11.00 price target on shares of NCI in a research report on Tuesday, April 4th. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $17.50.

Shares of NCI (NCIT) traded up 0.99% on Friday, hitting $20.50. 4,060 shares of the company traded hands. NCI has a 1-year low of $10.98 and a 1-year high of $21.00. The firm’s 50-day moving average is $18.39 and its 200 day moving average is $15.07. The firm has a market capitalization of $277.80 million, a P/E ratio of 45.86 and a beta of 0.98.

NCI (NASDAQ:NCIT) last issued its earnings results on Tuesday, May 9th. The information technology services provider reported $0.25 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.21 by $0.04. NCI had a return on equity of 11.73% and a net margin of 2.13%. The company had revenue of $78.75 million during the quarter, compared to the consensus estimate of $76.55 million. On average, analysts anticipate that NCI will post $1.01 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “ValuEngine Upgrades NCI, Inc. (NCIT) to Buy” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The legal version of this story can be read at https://www.thecerbatgem.com/2017/06/21/valuengine-upgrades-nci-inc-ncit-to-buy-updated-updated.html.

Hedge funds have recently bought and sold shares of the stock. ClariVest Asset Management LLC boosted its stake in NCI by 5.3% in the first quarter. ClariVest Asset Management LLC now owns 14,464 shares of the information technology services provider’s stock valued at $217,000 after buying an additional 727 shares in the last quarter. Algert Global LLC raised its position in shares of NCI by 10.8% in the first quarter. Algert Global LLC now owns 12,155 shares of the information technology services provider’s stock worth $183,000 after buying an additional 1,180 shares during the last quarter. Bank of New York Mellon Corp raised its position in shares of NCI by 4.4% in the first quarter. Bank of New York Mellon Corp now owns 27,972 shares of the information technology services provider’s stock worth $421,000 after buying an additional 1,184 shares during the last quarter. Dimensional Fund Advisors LP raised its position in shares of NCI by 1.0% in the first quarter. Dimensional Fund Advisors LP now owns 303,739 shares of the information technology services provider’s stock worth $4,571,000 after buying an additional 3,044 shares during the last quarter. Finally, LSV Asset Management raised its position in shares of NCI by 5.7% in the first quarter. LSV Asset Management now owns 72,201 shares of the information technology services provider’s stock worth $1,086,000 after buying an additional 3,903 shares during the last quarter. Hedge funds and other institutional investors own 39.04% of the company’s stock.

About NCI

NCI, Inc is a provider of enterprise services and solutions to defense, intelligence, healthcare and civilian government agencies. The Company provides information technology (IT), and professional services and solutions by leveraging its core service offerings, which include cloud computing and IT infrastructure optimization; cybersecurity and information assurance; engineering and logistics support; enterprise information management and advanced analytics; health IT and medical support; IT service management; modeling, simulation, and training, and agile development and integration.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Stock Ratings for NCI Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCI Inc. and related stocks with our FREE daily email newsletter.